Method for amplifying target genes having specific GC content

Abstract

The present invention provides a method for amplifying at least one target gene having a GC content of 60% or greater in a reaction solution, wherein: the method includes a step for amplifying a base sequence specific to a target gene using a primer set composed of a first primer and a second primer for amplifying the target gene; one of the primers in the primer set is added to the reaction solution in a higher molar ratio than the other primer; and neither of the primers is a hot-start primer that includes an inactivating chemical modification restored by the action of an activating enzyme.

Description

[Technical field]

[0001] The present invention broadly relates to a method for amplifying a target gene having a specific GC content in a reaction solution using asymmetric PCR.

[0002] Pseudomonas aeruginosa is a common bacterium present in human epithelium and the intestinal tract, and is a representative species of opportunistic infection. Multidrug-resistant Pseudomonas aeruginosa that has acquired drug resistance often causes outbreaks of hospital-acquired infections. Therefore, Pseudomonas aeruginosa is one of the species that is being closely monitored in medical institutions. [Prior art documents] [Patent documents]

[0003] [Patent Document 1] Special Publication No. 2015-536653 Summary of the Invention [Problem to be solved by the invention]

[0004] It is generally known that genes possessed by organisms have a composition of constituent bases and a GC content unique to that species. Pseudomonas aeruginosa is a bacterium characterized by a high GC content. For example, the analysis of the whole genome of the PA01 strain revealed that the GC content was 66.6% (Stover, CK, Pham, XQ, Erwin, AL, Mizoguchi, SD, Warrener, P., Hickey, MJ, Brinkman, FS, Hufnagle, WO, Kowalik, DJ, Lagrou, M. et al. 2000. Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature 406: 959-964.).

[0005] However, it was found that when targeting a bacterial species having genes with a high GC content, such as Pseudomonas aeruginosa, the amount of synthesis of the amplification product of the target gene decreases, resulting in a decrease in detection sensitivity. The decrease in detection sensitivity is particularly problematic in methods for simultaneously amplifying genes in samples containing multiple bacterial species to be differentiated in addition to the target gene and the target bacterial species containing it. Such simultaneous amplification methods for multiple genes are often called multiplex PCR, which is a technique that can amplify multiple gene fragments from one template DNA in one reaction system. Multiplex PCR, which has excellent throughput, can also amplify each gene fragment from multiple template DNAs present in the reaction system, and has become an indispensable technology in genetic diagnostics. [Means for solving the problem]

[0006] In order to solve such problems, the inventors of the present invention have conducted extensive research and have created a technology that combines a detection technology for target genes (also called genes of interest (GOI)) with high GC content with asymmetric PCR, which can comprehensively and simultaneously detect not only target genes with a low GC content (GC content: 40-60%) but also GOIs with a high GC content of 60% or more with high sensitivity and specificity, thereby completing the present invention.

[0007] That is, the present application includes the following inventions. [1] A method for amplifying at least one target gene having a GC content of 60% or more in a reaction solution, comprising the step of amplifying a base sequence specific to the target gene using a primer set consisting of a first primer and a second primer for amplifying the target gene, A method in which one primer of a primer set is added to a reaction mixture at a higher molar ratio than the other primer, and each primer is not a hot start primer that contains an inactivating chemical modification that is restored by the action of an activating enzyme. [2] The method according to [1], wherein the reaction solution contains one or more genes other than the target gene, and the method includes simultaneously amplifying the one or more genes other than the target gene together with the target gene. [3] The method according to [1] or [2], wherein the molar ratio of primers in the primer set is 1:1.5 to 20.0. [4] The method according to any one of [1] to [3], wherein the target gene is a base sequence consisting of at least 13 consecutive bases in the genome sequence of Pseudomonas aeruginosa. [5] The method according to any of [1] to [4], wherein the first primer hybridizes under stringent conditions with a nucleotide sequence set forth in any one of SEQ ID NOs: 1 to 3, or with a nucleotide sequence in which one or several bases have been deleted, substituted, inserted or added in the nucleotide sequence set forth in any one of SEQ ID NOs: 1 to 3, and the second primer hybridizes under stringent conditions with a complementary strand sequence of the nucleotide sequence set forth in any one of SEQ ID NOs: 1 to 3, or with a complementary strand sequence of the nucleotide sequence set forth in any one of SEQ ID NOs: 1 to 3, or with a nucleotide sequence in which one or several bases have been deleted, substituted, inserted or added. [6] The method according to any of [1] to [5], wherein the first primer is an oligonucleotide consisting of at least 13 consecutive bases in the base sequence set forth in SEQ ID NO: 4, or in a base sequence in which one or several bases have been deleted, substituted, inserted or added in the base sequence set forth in SEQ ID NO: 4. [7] The method according to any of [1] to [6], wherein the second primer is an oligonucleotide consisting of at least 13 consecutive bases in the base sequence set forth in SEQ ID NO: 5, or in a base sequence in which one or several bases have been deleted, substituted, inserted or added in the base sequence set forth in SEQ ID NO: 5. [8] The method according to any one of [1] to [7], wherein the primer is labeled with biotin. [9] The method according to any one of [1] to [8], wherein the primer with a higher molar ratio is labeled with biotin.

[10] A method for detecting at least one target gene having a GC content of more than 60% in a single reaction solution, comprising: A method comprising the step of detecting a target gene using a probe complementary to a single strand of the target gene amplified by the method according to any one of [1] to [9].

[11] The method according to

[10] , wherein the probe is complementary to a single strand of a target gene amplified by a high molar ratio of primers.

[12] The method according to

[10] or

[11] , wherein the target gene is detected by the presence of a double-stranded gene formed complementary to a single strand of the target gene and a probe.

[13] The method according to any one of [1] to

[12] , wherein the target gene is derived from Pseudomonas aeruginosa and Pseudomonas aeruginosa genes are differentiated from other bacterial genes.

[14] The method according to any one of

[10] to

[13] , wherein the probe is immobilized on a detection substrate material.

[15] The method according to any one of

[10] to

[14] , wherein the probe is labeled.

[16] The method according to any of

[10] to

[15] , wherein the probe nucleic acid is an oligonucleotide consisting of at least 13 consecutive bases in the base sequence set forth in SEQ ID NO: 6, or in a base sequence in which one or several bases have been deleted, substituted, inserted or added in the base sequence set forth in SEQ ID NO: 6.

[17] The method according to any one of

[14] to

[16] , wherein the detection substrate material is an encoded microcarrier.

[18] Microcarriers: (a) a substantially transparent polymeric layer having a first surface and a second surface, the first and second surfaces of the layer being parallel to one another; (b) a substantially opaque polymer layer affixed to the first surface of the substantially transparent polymer layer and surrounding a central portion of the substantially transparent polymer layer, the substantially opaque polymer layer including a two-dimensional shape representing an analog code; and (c) a capture agent for capturing an analyte, the capture agent being coupled to at least one of the first surface and the second surface of the substantially transparent polymeric layer in at least the central portion of the substantially transparent polymeric layer; The method according to

[17] , wherein the microcarrier comprises:

[19] A primer set for detecting the presence of at least one target gene having a GC content of 60% or more, comprising a first primer and a second primer, the first primer is an oligonucleotide consisting of at least 13 consecutive bases in the base sequence shown in SEQ ID NO: 4 or in the base sequence shown in SEQ ID NO: 4 in which one or several bases have been deleted, substituted, inserted or added, A primer set, wherein the second primer is an oligonucleotide consisting of at least 13 consecutive bases in the base sequence set forth in SEQ ID NO: 5, or in a base sequence in which one or several bases have been deleted, substituted, inserted or added in the base sequence set forth in SEQ ID NO: 5.

[20] The primer set described in

[19] , wherein the target gene is a base sequence consisting of at least 13 consecutive bases in the genome sequence of Pseudomonas aeruginosa.

[21] The primer set according to

[19] or

[20] , wherein the first primer is a primer that hybridizes under stringent conditions with a nucleotide sequence set forth in any one of SEQ ID NOs: 1 to 3, or a nucleotide sequence in which one or several bases have been deleted, substituted, inserted or added in the nucleotide sequence set forth in any one of SEQ ID NOs: 1 to 3, and the second primer is a primer that hybridizes under stringent conditions with a complementary strand sequence of the nucleotide sequence set forth in any one of SEQ ID NOs: 1 to 3, or a nucleotide sequence in which one or several bases have been deleted, substituted, inserted or added in the complementary strand sequence of the nucleotide sequence set forth in any one of SEQ ID NOs: 1 to 3.

[22] The primer set according to any one of

[19] to

[21] , wherein the first primer is an oligonucleotide consisting of at least 13 consecutive bases in the base sequence set forth in SEQ ID NO: 4, or in a base sequence in which one or several bases have been deleted, substituted, inserted or added in the base sequence set forth in SEQ ID NO: 4.

[23] The primer set according to any one of

[19] to

[22] , wherein the second primer is an oligonucleotide consisting of at least 13 consecutive bases in the base sequence set forth in SEQ ID NO: 5, or in a base sequence in which one or several bases have been deleted, substituted, inserted or added in the base sequence set forth in SEQ ID NO: 5. Effect of the Invention

[0008] According to the present invention, by using asymmetric PCR, it becomes possible to detect genes with high GC content with high sensitivity. [Brief description of the drawings]

[0009] [Figure 1] FIG. 1 shows the results of multiple alignment of the oprL genes (SEQ ID NOs: 1, 2, and 3) of P. aeruginosa strains E6130952, NCTC10332, and PAO1. [Diagram 2] FIG. 2 shows the results of comparing the fluorescence values ​​of conventional PCR and asymmetric PCR performed using genomic DNA extracted from the P. aeruginosa JCM14847 strain as a template. [Diagram 3] FIG. 3 shows the results of the amplification factor when genomic DNA extracted from the P. aeruginosa JCM14847 strain and templates with different GC contents were amplified using asymmetric PCR. [Figure 4] Figure 4 shows a comparison of the fluorescence values ​​between conventional PCR and asymmetric PCR performed using genomic DNA extracted from culture medium containing P. aeruginosa and Enterococcus caceliflavus as a template. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0010] Hereinafter, an embodiment of the present invention (hereinafter, referred to as "the present embodiment") will be described, but the scope of the present invention should not be interpreted as being limited to the following embodiment.

[0011] (Gene amplification and detection methods) In a first embodiment, a method for amplifying at least one target gene having a GC content of 60% or more in a reaction solution is provided. The amplification method may include a step of amplifying a base sequence specific to the target gene using a primer set consisting of a first primer and a second primer for amplifying the target gene, and optionally other steps. The amplification step includes a step of contacting the primer set with the target gene. The reaction solution may contain one or more genes other than the target gene, in which case the target gene and the one or more other genes are subjected to an amplification reaction simultaneously.

[0012] The target gene, also called gene of interest (GOI), may be any gene with a GC content of 60% or more. When performing an amplification reaction by multiplex PCR, the target gene is preferably a gene with a relatively high GC content among multiple genes of interest. The GC content is the ratio (%) of G bases and C bases in the DNA strand constituting the target gene, and is determined by performing sequence analysis of the target gene. Examples of bacteria with a target gene of 60% or more include, in addition to the above-mentioned Pseudomonas aeruginosa, Mycobacterium tuberculosis (65.86%), Propionibacterium acnes (60.3%), Bifidobacterium longum (60.84%); Bifidobacterium animalis (61.36%), etc., but are not limited to these bacteria. An example of a target gene is the oprL gene (GC content: 62.3%) of P. aeruginosa. The oprL gene encodes the precursor of peptidoglycan lipoprotein of P. aeruginosa.

[0013] The target gene amplification step is carried out under the amplification conditions of asymmetric PCR. For example, the molar ratio of primers added to the reaction solution for amplifying the target gene is adjusted so that the concentration of one primer is higher than that of the other primer. JP2015-536653A (above) discloses a hot start primer containing an inactive chemical modification that is restored by the action of an activating enzyme as a primer used in asymmetric PCR, but the primer set used in the present gene amplification method does not contain an inactive chemical modification that is restored by the action of an activating enzyme, such as a hot start primer (ribo primer). On the other hand, the primer used for amplifying genes other than the target gene may be any primer, and the amounts of forward primer and reverse primer added may be the same molar ratio.

[0014] The molar ratio of the primers for amplifying the target gene is not particularly limited as long as the target gene can be efficiently amplified in comparison with normal PCR, but is appropriately adjusted within the range of 1:1.5 to 20.0 in the reaction solution before amplification, for example. From the viewpoint of further increasing the fluorescence intensity, the molar ratio is preferably 1:1.5 to 3.5, more preferably 1.5 to 3.0, and even more preferably 1.5 to 2.5. When the target gene is amplified under asymmetric PCR conditions, the single strand, which is the amplification product of the primer added in excess, is produced in greater amounts than the single strand amplified by the other primer, and therefore the efficiency of formation of the complementary strand between the single strand and the probe is also increased. There may be a plurality of target genes, and in that case, it is necessary to prepare different primer sets for each different target gene.

[0015] The design of primer sequences for amplifying a target gene can be appropriately determined by a person skilled in the art with reference to the sequence of the target gene to be amplified. It is preferable that the primers used in asymmetric PCR are prepared so that the Tm values ​​of the forward primer and the reverse primer are approximately the same. For example, when the target gene is a Pseudomonas aeruginosa gene, a primer complementary to a base sequence consisting of at least 13 consecutive bases in the genome sequence is synthesized. An example of a target gene of Pseudomonas aeruginosa is the oprL gene, which has a GC content of about 62%. The oprL gene is one of the genes that encode outer membrane proteins, and its sequence differs from strain to strain. For example, the oprL genes of Pseudomonas aeruginosa strains E6130952, NCTC10332, and PAO1 have the base sequences of SEQ ID NOs: 1, 2, and 3, respectively.

[0016] The oprL gene has a base sequence shown in any one of SEQ ID NOs: 1 to 3, or has a base sequence shown in any one of SEQ ID NOs: 1 to 3 in which one or more bases have been deleted, substituted, inserted or added, and encodes the OprL protein.

[0017] The first primer as a forward primer may have any sequence as long as it can hybridize under stringent conditions to a base sequence set forth in any one of SEQ ID NOs: 1 to 3, or a base sequence in which one or several bases have been deleted, substituted, inserted or added in the base sequence set forth in any one of SEQ ID NOs: 1 to 3.

[0018] The second primer as a reverse primer may have any sequence as long as it can hybridize under stringent conditions to a complementary strand sequence of the base sequence set forth in any one of SEQ ID NOs: 1 to 3, or a complementary strand sequence of the base sequence set forth in any one of SEQ ID NOs: 1 to 3 in which one or several bases have been deleted, substituted, inserted or added.

[0019] As used herein, "stringent conditions" refers to conditions under which so-called specific hybrids are formed and non-specific hybrids are not formed, and can be appropriately determined based on information such as the length of the base sequence. For example, stringent conditions can be set with reference to Molecular Cloning (Fourth Edition, Cold Spring Harbor Laboratory Press, New York). Stringent conditions can also be said to be conditions under which polynucleotides having high homology (preferably identity), for example, polynucleotides having a homology of 70% or more, preferably 80% or more, more preferably 90% or more, even more preferably 95% or more, particularly preferably 99% or more, hybridize with each other, and polynucleotides showing a lower homology do not hybridize with each other.

[0020] Specific stringent conditions include incubating a base sequence complementary to the desired base sequence and a sample suspected of containing the target gene or a bacterial species having the target gene in a hybridization solution (50% formamide, 10xSSC (0.15M NaCl, 15mM sodium citrate, pH 7.0), 5xDenhardt's solution, 1% SDS, 10% dextran sulfate, 10μg / ml denatured salmon sperm DNA, and 50mM phosphate buffer (pH 7.5)) at about 42°C to about 50°C, and then washing with 0.1xSSC, 0.1% SDS at about 65°C to about 70°C.

[0021] Examples of the first primer targeting the oprL gene of Pseudomonas aeruginosa include a primer having the nucleotide sequence set forth in SEQ ID NO: 4 below, or a primer having a nucleotide sequence containing at least 13 consecutive nucleotides in the nucleotide sequence set forth in SEQ ID NO: 4 in which one or several nucleotides have been deleted, substituted, inserted or added, and having the same function as the nucleotide sequence set forth in SEQ ID NO: 4. 5'-GGTAAAGAGCGTCCGGTC-3' (SEQ ID NO: 4)

[0022] Examples of the second primer targeting the oprL gene of Pseudomonas aeruginosa include a primer having the nucleotide sequence set forth in SEQ ID NO:5 below, or a primer having a nucleotide sequence containing at least 13 consecutive nucleotides in the nucleotide sequence set forth in SEQ ID NO:5 in which one or several nucleotides have been deleted, substituted, inserted or added, and having the same function as the nucleotide sequence set forth in SEQ ID NO:5. 5'-TTACTTCTTCAGCTCGACG-3' (SEQ ID NO:5)

[0023] The first and second primers can specifically amplify all or a part of the target gene, which allows the target gene to be differentiated from other genes. Alternatively, the target gene (or a bacterial species having the target gene) can be differentiated from other genes (or other bacterial species having the target gene) by subjecting the amplified product of the first and second primers to melting curve analysis and comparing the melting temperature with the melting temperature of the amplified product of other primer sets.

[0024] The GC content of genes other than those contained in the bacterial species to be differentiated, more specifically, genes other than the target genes, which are derived from a bacterial species other than the species to be differentiated, is not particularly limited, but is preferably less than 60%.

[0025] The length of the primer for amplifying a gene other than the target gene is arbitrary and can be appropriately set within the range of, for example, about 10 bases to about 35 bases, but is preferably 10 bases or more.

[0026] The ratio of primers for amplifying genes other than the target gene is not particularly limited, and may be the same or different from each other. When a primer set is used in asymmetric PCR, the concentration of one primer may be adjusted to be higher than the concentration of the other primer.

[0027] Examples of bacteria with a GC content of less than 60% include, but are not limited to, Staphylococcus epidermidis, Proteus mirabilis, and Acinetobacter baumannii. Other examples include Citrobacter spp., such as Citrobacter koseri, Citrobacter freundii, Citrobacter braachii, and Citrobacter amalonaticus; Enterobacter spp., such as Enterobacter cloacae and Enterobacter asburiae; Escherichia coli, Klebsiella aerogenes, Klebsiella pneumoniae, Klebsiella oxytoca, and Klebsiella variicola; Serratia marcescens; Enterococcus casseriflavus, Enterococcus faecalis, and Enterobacter spp. Examples of bacteria with a GC content of less than 60% include Enterococcus genus such as Enterococcus faecium; Listeria genus such as Listeria monocytogenes; Staphylococcus genus such as Staphylococcus aureus / Staphylococcus hominis; Streptococcus genus such as Streptococcus pyogenes / Streptococcus pneumoniae / Streptococcus oralis; and Candida genus such as Corynebacterium jejunum, Neisseria meningitidis, and Candida albicans.

[0028] The primer set for amplifying the target gene is not limited to the combination of the first and second primers, and may include these first and second primers and other primers, such as third, fourth, fifth, sixth, etc., additional primers. The detection sensitivity can be improved by using appropriate additional primers. As such primers, for example, primers for amplifying a region of the target gene different from the region amplified by the first and second primers, etc. are envisioned.

[0029] The presence of a target gene or a bacterial species having the target gene contained in a sample can be detected by a nucleic acid amplification reaction using the above primers. From the viewpoint of efficiency, it is preferable to carry out the amplification and detection of the target gene in one reaction solution. For detection of the amplified product after the nucleic acid amplification reaction, a label capable of specifically recognizing the amplified product may be used. Examples of such a label include fluorescent dyes, biotin, digoxigenin, and the like. The primer to be labeled may be any primer, but in the case of a primer set used in asymmetric PCR, it is preferable to label a primer having a high molar ratio. The site to be labeled is not limited, but it is preferable to place the primer directly or via a linker at the 5' end of the primer.

[0030] When a probe is used, the target gene can be detected by the presence of a double-stranded gene formed by the complementary formation of the probe with the single strand of the target gene amplified by asymmetric PCR. The probe is preferably designed to be complementary to the single strand of the target gene amplified by a primer with a high molar ratio. When a fluorescent substance is used as a label, the fluorescence can be detected using a fluorescent microscope, a fluorescent plate reader, or the like.

[0031] An example of the probe is the probe shown in SEQ ID NO: 6 that captures the PCR product of Pseudomonas aeruginosa strain JCM 14847. When the nucleic acid encoding the probe has the base sequence shown in SEQ ID NO: 6, the nucleic acid may be composed of an oligonucleotide consisting of at least 13 consecutive bases in the base sequence or in the base sequence shown in SEQ ID NO: 6 in which one or several bases have been deleted, substituted, inserted or added.

[0032] The polynucleotides constituting the primers, probes, etc. may be immobilized on a detection substrate, etc. The substrate may be any material capable of immobilizing and holding the polynucleotide, and may be made of various materials such as glass, plastic, fibers, etc. The substrate material may be in the form of a microcarrier such as a microarray, which may be in the form of a disk or beads.

[0033] For multiplex assays, the surface of the microcarriers is preferably coded with a unique identifier, such as a barcode. (a) a substantially transparent polymeric layer having a first surface and a second surface, the first and second surfaces of the layer being parallel to one another; (b) a substantially opaque polymer layer affixed to the first surface of the substantially transparent polymer layer and surrounding a central portion of the substantially transparent polymer layer, the substantially opaque polymer layer including a two-dimensional shape representing an analog code; and (c) a capture agent for capturing an analyte, the capture agent being coupled to at least one of the first surface and the second surface of the substantially transparent polymeric layer in at least the central portion of the substantially transparent polymeric layer; may include:

[0034] The specimen providing the target gene is not particularly limited as long as it is suspected of containing the target gene or a bacterial species having the gene, and examples thereof include human or non-human body fluids such as blood, serum, plasma, urine, stool, saliva, sputum, tissue fluid, cerebrospinal fluid, swabs, and the like, or dilutions thereof, with blood, serum, plasma, urine, stool, cerebrospinal fluid, or dilutions thereof being preferred. The specimen may also be food, soil, plants, and the like.

[0035] In addition to the primers and sample, the reaction solution also contains a PCR buffer containing DNA polymerase enzyme, substrate, and magnesium ions.

[0036] PCR may be a singleplex assay in which only the target gene is amplified, or a multiplex assay in which the target gene and one or more other genes are simultaneously amplified.

[0037] Multiplex assays such as multiplex PCR are well known to those skilled in the art. One of the techniques for multiplex assays is π-code technology, which identifies the type of test subject by fixing an antibody or a probe for gene measurement to a magnetic microdisk with a barcode engraved on its surface, enabling simultaneous measurement of multiple items. The π-code technology is disclosed, for example, in WO2016 / 198954 (JP2018-518146A) or WO2018 / 052464 (JP2019-535003A), and the contents of these publications are incorporated herein by reference in their entirety.

[0038] The present invention will be specifically described below by showing examples, but the present invention is not limited to these examples. EXAMPLES

[0039] Example 1: Comparison of detection results on a substrate using a DNA probe targeting the genome of Pseudomonas aeruginosa in conventional PCR and asymmetric PCR (1) Primer and probe design Based on the multiple alignment results of the oprL genes (SEQ ID NOs: 1, 2, and 3) of P. aeruginosa strains E6130952, NCTC10332, and PAO1 shown in Figure 1, primers SEQ ID NOs: 4 and 5 and a probe SEQ ID NO: 6 were designed. The GC content of the oprL gene is 62.3%. The above primers do not contain inactive chemical modifications that are restored by the action of an activating enzyme.

[0040] (2) Nucleic acid amplification and detection Using genomic DNA extracted from P. aeruginosa JCM14847 strain as a template, normal PCR was performed using primers of SEQ ID NO: 4 and SEQ ID NO: 5 at a molar ratio of 1:1, and asymmetric PCR was performed using primers of SEQ ID NO: 4 and SEQ ID NO: 5 at a molar ratio of 1:2.5, and hybridization reaction, labeling, and fluorescence measurement were performed on the substrate. A magnetic microcarrier (manufactured by PlexBio) with a barcode engraved on the surface was used as the substrate. In this case, a primer with biotin modification via a linker was used at the 5' end of SEQ ID NO: 5.

[0041] The TaKaRa Multiplex Assay Kit Ver.2 (Takara Bio) was used for amplification. In normal PCR, each primer was added to a final concentration of 0.2 μM. In asymmetric PCR, each primer was added to a final concentration of 0.2 μM and 0.5 μM. 200 pg of template genomic DNA was added per reaction. The 2×Reaction buffer in the TaKaRa Multiplex Assay Kit Ver.2 was added to a final concentration of 1x, and the Multiplex Enzyme Mix was added to a final concentration of 1U. The nucleic acid amplification device used was a T100 Thermal Cycler (Bio-Rad). After the amplification reaction was completed, a thermal denaturation reaction was performed using the same device before the hybridization reaction on the substrate.

[0042] The reagents used for the hybridization reaction on the substrate were prepared by mixing a solution containing a substrate on which the probe of sequence number 6 that captures the PCR product of P. aeruginosa JCM14847 strain was immobilized, saline-sodium-phosphate-EDTA buffer (SSPE-buffer), and a PCR reaction solution that had been heat-denatured.

[0043] Streptavidin-phycoerythrin (PlexBio) was used as a reagent for labeling. The hybridization reaction and labeling on the substrate were performed using an IntelliPlex 1000 πCode Processor (PlexBio). The fluorescence measurement device used was a PlexBio (registered trademark) 100 Fluorescent Analayzer (PlexBio).

[0044] The conditions used were as follows: Amplification reaction conditions: 94℃ 30 seconds 60℃ 60 seconds -> 94℃ 30 seconds (30 cycles) 72℃ 600 seconds

[0045] Heat denaturation conditions: 95℃ 5 minutes -> Rapid cooling to 4℃

[0046] Hybridization conditions: Incubate at 37℃ for 20 minutes

[0047] Labeling conditions: Incubate at 37℃ for 10 minutes.

[0048] (3) Measurement results The measurement results are shown in Figure 2. When genomic DNA extracted from the P. aeruginosa JCM14847 strain was used as a template, the fluorescence value obtained by normal PCR was 27,195, whereas the fluorescence value obtained by asymmetric PCR was 87,818. From the above, it was found that the application of asymmetric PCR to the detection of P. aeruginosa increased the sensitivity by approximately three-fold.

[0049] Example 2: Differences in the sensitization effect of asymmetric PCR when templates with different GC contents are used (1) Nucleic acid amplification and detection Using genomic DNA extracted from P. aeruginosa JCM14847 strain as a template, normal PCR was performed using primers of SEQ ID NO: 4 and SEQ ID NO: 5 in a 1:1 molar ratio, and asymmetric PCR was performed using primers of SEQ ID NO: 4 and SEQ ID NO: 5 in a 1:2.5 molar ratio, followed by hybridization reaction on a substrate, labeling, and fluorescence measurement. In this case, a primer modified with biotin via a linker at the 5' end of SEQ ID NO: 5 was used.

[0050] As a first comparison, genomic DNA extracted from Staphylococcus epidermidis JCM2414 strain was used as a template to carry out normal PCR using primers of SEQ ID NO:7 and 8 in a 1:1 molar ratio, and asymmetric PCR using primers of SEQ ID NO:7 and 8 in a 1:2.5 molar ratio, and hybridization reaction on a substrate, labeling, and fluorescence measurement were carried out. In this case, a primer with biotin modification via a linker was used at the 5' end of SEQ ID NO:8.

[0051] As a second comparison, a normal PCR was performed using the genomic DNA extracted from Proteus mirabilis JCM1669 strain as a template, with the primers of SEQ ID NO:10 and 11 in a molar ratio of 1:1, and an asymmetric PCR was performed using the primers of SEQ ID NO:10 and 11 in a molar ratio of 1:2.5, and hybridization reaction, labeling, and fluorescence measurement on a substrate were performed. In this case, a primer with biotin modification via a linker was used at the 5' end of SEQ ID NO:11.

[0052] Finally, as the third comparison target, normal PCR was performed using genomic DNA extracted from Acinetobacter baumannii JCM6841 strain as a template, with primers of SEQ ID NO:13 and 14 in a molar ratio of 1:1, and asymmetric PCR was performed using primers of SEQ ID NO:13 and 14 in a molar ratio of 1:2.5, and hybridization reaction on a substrate, labeling, and fluorescence measurement were performed. In this case, a primer with biotin modification via a linker was used at the 5' end of SEQ ID NO:14.

[0053] TaKaRa Multiplex Assay Kit Ver.2 (Takara Bio) was used for amplification. Primers were added to a final concentration of 0.2 μM in normal PCR. Primers were added to final concentrations of 0.2 μM and 0.5 μM in asymmetric PCR. 200 pg of template genomic DNA was added per reaction. The 2×Reaction buffer in the TaKaRa Multiplex Assay Kit Ver.2 was added to a final concentration of 1x, and Multiplex Enzyme Mix was added to a final concentration of 1U. The nucleic acid amplification device used was a T100 Thermal Cycler (Bio-Rad). After the amplification reaction was completed, a thermal denaturation reaction was performed using the same device before subjecting the samples to a hybridization reaction on the substrate.

[0054] The reagents used for the hybridization reaction on the substrate were a mixture of a solution containing a substrate on which the probes of SEQ ID NOs: 6, 9, 12, and 15 were immobilized, a saline-sodium-phosphate-EDTA (SSPE) buffer, and a PCR reaction solution that had been thermally denatured. Here, the probe of SEQ ID NO: 9 is a probe that captures the PCR product of S. epidermidis, the probe of SEQ ID NO: 12 is a probe that captures the PCR product of P. mirabilis, and the probe of SEQ ID NO: 15 is a probe that captures the PCR product of A. baumannii.

[0055] The reagents used for labeling, the equipment used for the hybridization reaction on the substrate and labeling, and the fluorescence measuring device and conditions were the same as those in Example 1.

[0056] (2) Measurement results FIG. 3 shows the results of plotting the fluorescence value in asymmetric PCR divided by the fluorescence value in normal PCR as the enhancement factor on the horizontal axis and the GC content of the PCR products of each item shown in SEQ ID NOs: 16, 17, 18, and 19 on the vertical axis. Here, the enhancement factor means the value obtained by dividing the fluorescence value when an amplification reaction is carried out using asymmetric PCR and detection is carried out using the obtained amplification product by the fluorescence value when an amplification reaction is carried out using normal PCR and detection is carried out using the obtained amplification product, and the higher the enhancement factor, the higher the detection sensitivity is compared to normal PCR. From the results in FIG. 3, it can be seen that the enhancement factor increases depending on the GC content when the GC content is low, and the increase in the enhancement factor, i.e., the increase in detection sensitivity, becomes significant when the GC content of the target gene is 60% or more.

[0057] As shown in Figure 3, a positive correlation was confirmed between the sensitization rate and the GC content. The reason for this correlation is thought to be that the rate of the hybridization reaction of nucleic acids is highly dependent on the composition of the nucleic acid. A model has been proposed in which some complementary bases between two molecules with complementary sequences repeatedly approach and separate, and when they eventually associate with a completely complementary sequence, they form base pairs like a zipper. A calculation using an 8-base model sequence showed that the base pairing rate of a GC-rich sequence was 3.2 times faster than that of an AT-rich sequence, and it has been reported that a GC-rich sequence associates with its complementary sequence more quickly to form a complementary strand (DNA hybridization kinetics: zippering, internal displacement and sequence dependence. Nucleic Acids Res. 2013 Oct; 41(19): 8886-8895.).

[0058] In this embodiment, the target of capture on the substrate is a PCR product that has been amplified as double-stranded DNA and thermally denatured. Therefore, it is considered that the hybridization reaction of the PCR product proceeds in a form in which the partial complementary strand formation with the probe on the substrate and the complementary strand formation with the PCR product coexist. From the above measurement results, it is considered that the higher the GC content of the product, the more accelerated the capture reaction by the probe as well as the complementary strand formation between the PCR products. Although the capture reaction by the probe is not performed satisfactorily in normal PCR, the capture reaction by the probe is effectively performed by applying asymmetric PCR and overproducing the molecules to be captured on the substrate, resulting in a significant sensitization effect.

[0059] On the other hand, in the case of A. baumannii, which has a low GC content, the enhancement factor was 0.92, and it was found that the fluorescence value decreased when asymmetric PCR was performed. In detection on the substrate, two types of hybridization reactions occur, with partial complementary strand formation with the probe on the substrate and complementary strand formation with the PCR product coexisting, and it is assumed that many parameters such as the number of molecules to be captured, GC content, and base pair formation rate are related and output to the final fluorescence value. It is known that asymmetric PCR reduces the yield of PCR products compared to normal PCR, and the results of this study indicate that asymmetric PCR may be disadvantageous for target genes with low GC content.

[0060] These results demonstrate that the application of asymmetric PCR to detect templates with a GC content of 60% or more improves detection sensitivity.

[0061] Example 3: Simultaneous detection of genes with GC content of 60% or more and other genes (1) Nucleic acid amplification and detection Sample 1 was prepared, which was determined to contain two bacterial species, Pseudomonas aeruginosa (GC content of PA01 strain: 66.6%) and Enterococcus casseliflavus, by the culture identification method. The GC content of PA01 strain is known to be 66.6%, and the GC content of Enterococcus casseliflavus is known to be 42.9% (Sanderson, H., Ortega-Polo, R., Zaheer, R. et al. Comparative genomics of multidrug-resistant Enterococcus spp. isolated from wastewater treatment plants. BMC Microbiol 20, 20 (2020). https: / / doi.org / 10.1186 / s12866-019-1683-4).

[0062] The above specimens were amplified by multiplex PCR using genomic DNA extracted according to the standard protocol included with the reagent as a template, and hybridization reaction and labeling on a substrate and fluorescence measurement were performed using the QIAamp BiOstic Bacteremia DNA Kit (QIAGEN). As in Examples 1 and 2, a magnetic microcarrier (PlexBio) with a barcode engraved on the surface was used as the substrate. Other than that, the reagents used for labeling, the hybridization reaction on the substrate, the equipment used for labeling, the fluorescence measuring device, and other conditions were the same as in Examples 1 and 2 unless otherwise specified.

[0063] The amplification was performed using TaKaRa Multiplex Assay Kit Ver.2 (Takara Bio). The primers used were the primers shown in SEQ ID NO:4 and 5 for Pseudomonas aeruginosa and the primers shown in SEQ ID NO:20, 21, 22, and 23 for Enterococcus caceliflavus. In normal PCR, all primers were added to a final concentration of 0.2 μM. In asymmetric PCR, primers other than SEQ ID NO:5 were added to a final concentration of 0.2 μM, and the primer shown in SEQ ID NO:5 was added to a final concentration of 0.5 μM. Primers with biotin modification via a linker at the 5' end of SEQ ID NO:5 and 23 were used. 5 μL of template solution was added per reaction. The 2×Reaction buffer in the TaKaRa Multiplex Assay Kit Ver.2 was added to a final concentration of 1x, and Multiplex Enzyme Mix was added to a final concentration of 1U. The nucleic acid amplification device used was the T100 Thermal Cycler (Bio-Rad). After the amplification reaction was completed, a thermal denaturation reaction was carried out in the same device before the hybridization reaction on the substrate.

[0064] The reagents used for the hybridization reaction on the substrate were a solution containing substrate 1 on which a probe (sequence number 6) for capturing Pseudomonas aeruginosa was immobilized and substrate 2 on which a probe (sequence number 24) for capturing Enterococcus caceliflavus was immobilized, mixed with saline-sodium-phosphate-EDTA buffer (SSPE-buffer) and a PCR reaction solution that had been heat-denatured.

[0065] The fluorescence value after blank subtraction for substrate 1, on which a probe for capturing Pseudomonas aeruginosa was immobilized, was 1622 in normal PCR, but was 13731 when asymmetric PCR was applied, greatly improving the detection sensitivity. In addition, substrate 2, on which a probe for capturing Enterococcus caceliflavus was immobilized, had a sufficiently high detection sensitivity in normal PCR, but when Pseudomonas aeruginosa was amplified by asymmetric PCR, this did not adversely affect the results of substrate 1, and the detection sensitivity also increased in the results of substrate 2.

[0066] Therefore, asymmetric PCR was effective in simultaneously detecting genes with a GC content of 60% or more and other genes, confirming the effectiveness of the present invention.

Claims

1. A method for amplifying at least one target gene having a GC content of 60% or more and one or more genes other than the target gene in a reaction solution, comprising: The method includes a step of amplifying a base sequence specific to the target gene and one or more genes other than the target gene, using a primer set consisting of a first primer and a second primer for amplifying the target gene, and a primer set consisting of one or more forward primers and one or more reverse primers for amplifying a gene other than the target gene, In the above step, one of the primers in a primer set consisting of a first primer and a second primer is added to a reaction solution at a higher molar ratio than the other primer, and a forward primer and a reverse primer in a primer set for amplifying a gene other than the target gene are added to the reaction solution at the same molar ratio; A method wherein each primer is not a hot start primer, which primer contains an inactivating chemical modification that is restored by the action of an activating enzyme.

2. The method described in claim 1, wherein the molar ratio of primers in a primer set consisting of a first primer and a second primer is 1:1.5 to 3.

5.

3. 3. The method according to claim 1, wherein the target gene is a base sequence consisting of at least 13 consecutive bases in the genome sequence of Pseudomonas aeruginosa.

4. The method according to any one of claims 1 to 3, wherein the first primer hybridizes under stringent conditions with a base sequence set forth in any one of SEQ ID NOs: 1 to 3, or a base sequence in which one or several bases have been deleted, substituted, inserted or added in the base sequence set forth in any one of SEQ ID NOs: 1 to 3, and the second primer hybridizes under stringent conditions with a complementary strand sequence of the base sequence set forth in any one of SEQ ID NOs: 1 to 3, or a complementary strand sequence of the base sequence set forth in any one of SEQ ID NOs: 1 to 3, or a base sequence in which one or several bases have been deleted, substituted, inserted or added.

5. The method according to any one of claims 1 to 4, wherein the first primer is an oligonucleotide consisting of at least 13 consecutive bases in the base sequence set forth in SEQ ID NO: 4, or in the base sequence set forth in SEQ ID NO: 4 in which one or several bases have been deleted, substituted, inserted or added.

6. The method according to any one of claims 1 to 5, wherein the second primer is an oligonucleotide consisting of at least 13 consecutive bases in the base sequence set forth in SEQ ID NO: 5, or in the base sequence set forth in SEQ ID NO: 5 in which one or several bases have been deleted, substituted, inserted or added.

7. The method according to any one of claims 1 to 6, wherein the primer is labelled with biotin.

8. The method according to any one of claims 1 to 7, wherein the high molar ratio primer is labelled with biotin.

9. 1. A method for detecting at least one target gene having a GC content of more than 60% in a single reaction, comprising: A method comprising the step of detecting a target gene using a probe complementary to a single strand of the target gene amplified by the method according to any one of claims 1 to 8.

10. 10. The method of claim 9, wherein the probe is complementary to a single strand of a target gene amplified by a high molar ratio of primers.

11. 11. The method of claim 9 or 10, wherein the target gene is detected by the presence of a complementary double-stranded gene formation between a single strand of the target gene and the probe.

12. The method according to any one of claims 1 to 11, wherein the target gene is derived from Pseudomonas aeruginosa and Pseudomonas aeruginosa and other bacterial genes are differentiated.

13. The method according to any one of claims 9 to 12, wherein the probe is immobilised on a detection substrate material.

14. The method according to any one of claims 9 to 13, wherein the probe is labeled.

15. The method according to any one of claims 9 to 14, wherein the probe nucleic acid is an oligonucleotide consisting of at least 13 consecutive bases in the base sequence shown in SEQ ID NO: 6, or in the base sequence shown in SEQ ID NO: 6 in which one or several bases have been deleted, substituted, inserted or added.

16. The method of any one of claims 13 to 15, wherein the detection substrate material is an encoded microcarrier.

17. The microcarrier (a) a substantially transparent polymeric layer having a first surface and a second surface, a layer, the first and second surfaces being parallel to one another; (b) a substantially opaque polymer layer affixed to the first surface of the substantially transparent polymer layer and surrounding a central portion of the substantially transparent polymer layer, the substantially opaque polymer layer including a two-dimensional shape representing an analog code; and (c) a capture agent for capturing an analyte, the capture agent being coupled to at least one of the first surface and the second surface of the substantially transparent polymeric layer in at least the central portion of the substantially transparent polymeric layer. The method of claim 16, wherein the microcarrier comprises:

Images